Why This Biotech Fund Increased Its Oruka Stake Amid a 500% Rally
A biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
Extra expenses call for smart tweaks. This intro covers simple ways to adjust your budget to accommodate additional costs.
12,871 articlesA biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
Geopolitics in the Gulf is shifting fast. Qatar eyes a $1 billion missiles package from BAE Systems, a move that coul...
Rocket Lab has surged on new contracts and a growing backlog, yet investors wonder if the rally can last. This guide ...
As the U.S. labor market tightens, veterans are increasingly finding a clear path into high-demand trades. This repor...
MLB owners rolled out a formal salary cap plan, marking a rare shift in labor talks as the 2027 season looms. The mov...
When the government pours billions into quantum research, a surge in quantum stocks often follows. This guide breaks ...
The two most influential college sports leagues say the current federal bill fails to address key issues, signaling a...
In June, affordable stock ideas can offer surprising upside for patient investors. This article breaks down three und...
SpaceX's IPO could be a watershed moment for growth investors, but it carries meaningful risks. This guide breaks dow...
The canadian prime minister mark warns that U.S. export controls on Anthropic’s latest AI models show the dangers of ...
A striking market move has analysts buzzing: the stock market just flashed a rare bullish signal. This article breaks...
Australia seals its largest defense export to date with a $1.75 billion radar pact in Canada, expanding Arctic securi...